Pneumovax Related Clinical Trials
Study Evaluating Antibody Response of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children Previously Given PnC [Recruiting]
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria [Recruiting]
Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients [Not yet recruiting]
Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients [Recruiting]
Pneumococcal Conjugate Vaccine Followup [Recruiting]
Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX�23) in the Young and Elderly [Not yet recruiting]
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine [Recruiting]
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13� [Not yet recruiting]
Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine [Active, not recruiting]
Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis [Completed]
A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine [Recruiting]
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. [Recruiting]
An Alternative Booster Vaccine Against Meningitis and Ear Infections [Not yet recruiting]
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants [Recruiting]
Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults. [Completed]
Study Evaluating Prevenar Vaccine in Healthy Infants [Completed]
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Recruiting]
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults [Recruiting]
ZOSTAVAX(TM) Administered Concomitantly With PNEUMOVAX(TM) 23 [Completed]
"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency [Recruiting]
Study Comparing 13 Valente Pneumococcal Conjugate Vaccine With 7 Valent Pneumococcal Conjugate Vaccine [Active, not recruiting]
Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India [Completed]
Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time [Completed]
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Completed]
Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine [Recruiting]
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children [Recruiting]
Study Evaluating 13-Valent Pneumococal Conjugate Vaccine in Healthy Infants [Active, not recruiting]
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine. [Completed]
Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China [Recruiting]
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines [Not yet recruiting]
Pneumococcal Vaccines Early and in Combination [Recruiting]
Pneumococcal Conjugate Vaccine 13 (Prevnar13®) in Children Who Are Solid Organ Transplant Recipients (SOT) [Recruiting]
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrixâ„¢-Hexa, When Administered With Prevnar® in Thai Infants [Active, not recruiting]
Humoral Determinants of Immunity to Pneumococcal Infection [Recruiting]
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs [Active, not recruiting]
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Not yet recruiting]
Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants. [Active, not recruiting]
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children [Recruiting]
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population [Completed]
Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. [Recruiting]
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children [Active, not recruiting]
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Active, not recruiting]
Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenarâ„¢ and Hiberixâ„¢ [Recruiting]
Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-Treated Adults With Chronic Plaque Psoriasis [Active, not recruiting]
13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study [Not yet recruiting]
13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico [Recruiting]
Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-Valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) [Completed]
Revaccination With PNEUMOVAX(TM) 23 in Older Adults [Active, not recruiting]
Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes [Completed]
Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) [Completed]
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent) [Recruiting]
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. [Recruiting]
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A. [Recruiting]
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants [Not yet recruiting]
Vaccination Course in Primed Children and Age-Matched Unprimed Children With Pneumococcal Vaccine GSK1024850A. [Recruiting]
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination [Not yet recruiting]
Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants [Active, not recruiting]
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age [Completed]
Co-Administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus co-Administration With DTPa-HBV-IPV/Hib [Recruiting]
Study Investigating Administration of Prevenar for Post-Marketing Surveillance [Recruiting]
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults [Completed]
Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting [Recruiting]
Pneumococcal Adult-Dose Ranging Immunization Study [Active, not recruiting]
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine [Completed]
Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup [Recruiting]
Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort [Not yet recruiting]
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers [Recruiting]
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Recruiting]
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Recruiting]
Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Elderly Subjects [Completed]
Booster and Catch-up Vaccination With Vaccine GSK1024850A [Recruiting]
Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Infants [Active, not recruiting]
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-Valent Pneumococcal Conjugate Vaccine [Completed]
Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants [Active, not recruiting]
Study To Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Infants. [Active, not recruiting]
Pneumococcal Vaccination of Fiji Infants
Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine [Recruiting]
Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Korea [Recruiting]
Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan [Recruiting]
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants [Active, not recruiting]
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A [Active, not recruiting]
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age [Recruiting]
Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine [Active, not recruiting]
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age. [Not yet recruiting]
A Lot-to-Lot Consistency (3 Lots of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine) & Non-Inferiority Study [Completed]
Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine In Healthy Infants [Active, not recruiting]
Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A [Recruiting]
Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine [Recruiting]
Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease. [Recruiting]
Vaccination of Children Following Allogeneic Stem Cell Transplantation [Active, not recruiting]
Study to Evaluate a 13-Valent Pneumococcal Conjugate Vaccine in Elderly Subjects
Racial Disparities in Pneumococcal Vaccination in Managed Care [Completed]
Safety and Local Tolerability of Prevenar in Indian Children
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age [Completed]
Impact of Prevnar 13 on Ear Infections in Children [Recruiting]
Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa [Completed]
Study Evaluating Immune Response of Children Revaccinated With Pneumococcal Conjugate Vaccine [Recruiting]
Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea [Recruiting]
Study to Evaluate the Safety and Immunogenicity of a 10-Valent Pneumococcal Conjugate Vaccine in Preterm Infants [Completed]
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease [Recruiting]
|
